ISSN: 2387-0206

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine.
The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles.
Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, SciVerse ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

3.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.8

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.347

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.526

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers

Kits comercializados para evaluar la respuesta celular T frente a péptidos S del SARS-CoV-2. Un estudio piloto en trabajadores sanitarios

Mónica Martínez-Galloa,b,c,1, Juliana Esperalbad,1, Ricardo Pujol-Borrella,b,c, Víctor Sandáa, Iria Arrese-Muñoza, Candela Fernández-Navale,f, Andrés Antónd, Victoria Cardonag,h,i, Moisés Labrador-Horrillof,g,h,i,

Corresponding author

mlabrador@vhebron.net

Corresponding author.

, Tomás Pumarolad, Manuel Hernandéz-Gonzáleza,b,c

a Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center, Barcelona, Catalonia, Spain

b Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain

c Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain

d Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH), Departament de Genètica i Microbiologia, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain

e Microbiology Department, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain

f Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

g Allergy Section, Internal Medicine Department, Hospital Universitari Vall d’Hebron (HUVH), Barcelona, Catalonia, Spain

h ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Spain

i Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information